U.S. Markets closed

GCANRx offers oral patch with cannabinoid, as vaping-related illnesses increase

Vaping related illnesses continue to rise, prompting the FDA and CDC to launch an investigation. Meanwhile, GCANRx thinks that it has a possible solution, a patch that releases a certain amount of cannabinoid each use. GCANRx CEO Aitan Zacharin joins On The Move to discuss.